Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Amado Rodríguez, Laura ^a   González López, Adrián ^b   López Alonso, Inés ^b   Aguirre, Alina ^b   Astudillo, Aurora ^c   Batalla Solís, Estefanía ^a   Blazquez Prieto, Jorge ^b   García Prieto, Emilio ^a   Albaiceta, Guillermo M ^a,b,d  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

E selectin; Macrolides; Mechanical ventilation; Neutrophil migration

Indexed keywords

CLARITHROMYCIN; CXCL2 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LEVOFLOXACIN; AUTACOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HYPERBARISM; HYPOBARISM; INJURY SEVERITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PROTEIN EXPRESSION; VENTILATOR INDUCED LUNG INJURY; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; LUNG; PATHOLOGY; VENTILATOR-INDUCED LUNG INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLARITHROMYCIN; INFLAMMATION MEDIATORS; LEVOFLOXACIN; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; VENTILATOR-INDUCED LUNG INJURY;

EID: 84877298417     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-52     Document Type: Article

References (39)

1. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A, Gandia F, Carriedo D, Mosteiro F, Basaldua S. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011, 37:1932-1941. 10.1007/s00134-011-2380-4, 21997128.
2. Albaiceta GM, Blanch L. Beyond volutrauma in ARDS: The critical role of lung tissue deformation. Crit Care 2011, 15:304. 10.1186/cc10052, 3219320, 21489320.
3. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009, 151:566-576. 10.7326/0003-4819-151-8-200910200-00011, 19841457.
4. Rouby JJ, Brochard L. Tidal recruitment and overinflation in acute respiratory distress syndrome: yin and yang. Am J Respir Crit Care Med 2007, 175:104-106. 10.1164/rccm.200610-1564ED, 17200505.
5. Walkey AJ, Wiener RS. Macrolide antibiotics and survival in patients with acute lung injury. Chest 2012, 141:1153-1159. 10.1378/chest.11-1908, 3342785, 22116799.
6. Metersky ML, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones. Chest 2007, 131:466-473. 10.1378/chest.06-1426, 17296649.
7. Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Coalson JJ, Anzueto A. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J 2009, 33:153-159. 10.1183/09031936.00054108, 18768577.
8. Giamarellos-Bourboulis EJ, Pechere JC, Routsi C, Plachouras D, Kollias S, Raftogiannis M, Zervakis D, Baziaka F, Koronaios A, Antonopoulou A. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008, 46:1157-1164. 10.1086/529439, 18444850.
9. Kawasaki S, Takizawa H, Ohtoshi T, Takeuchi N, Kohyama T, Nakamura H, Kasama T, Kobayashi K, Nakahara K, Morita Y, Yamamoto K. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 1998, 42:1499-1502. 105630, 9624502.
10. Morikawa K, Zhang J, Nonaka M, Morikawa S. Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents 2002, 19:53-59. 10.1016/S0924-8579(01)00457-5, 11814768.
11. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm 2004, 13:313-319. 10.1080/09629350400008810, 1781582, 15770046.
12. Santos CC, Zhang H, Liu M, Slutsky AS. Bench-to-bedside review: Biotrauma and modulation of the innate immune response. Crit Care 2005, 9:280-286. 10.1186/cc3022, 1175867, 15987418.
13. Pedreira PR, Garcia-Prieto E, Parra D, Astudillo A, Diaz E, Taboada F, Albaiceta GM. Effects of melatonin in an experimental model of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2008, 295:L820-L827. 10.1152/ajplung.90211.2008, 18805959.
14. Nin N, Penuelas O, de Paula M, Lorente JA, Fernandez-Segoviano P, Esteban A. Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med 2006, 34:1093-1098. 10.1097/01.CCM.0000205663.92384.E7, 16484900.
15. Nakanishi Y, Kobayashi D, Asano Y, Sakurai T, Kashimura M, Okuyama S, Yoneda Y, Shapiro SD, Takayama K. Clarithromycin prevents smoke-induced emphysema in mice. Am J Respir Crit Care Med 2009, 179:271-278. 10.1164/rccm.200806-905OC, 19060231.
16. Tagliabue C, Techasaensiri C, Torres JP, Katz K, Meek C, Kannan TR, Coalson JJ, Esposito S, Principi N, Leff R. Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. J Antimicrob Chemother 2011, 66:2323-2329. 10.1093/jac/dkr306, 3172041, 21791441.
17. Albaiceta GM, Gutierrez-Fernandez A, Garcia-Prieto E, Puente XS, Parra D, Astudillo A, Campestre C, Cabrera S, Gonzalez-Lopez A, Fueyo A. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. Am J Respir Cell Mol Biol 2010, 43:555-563. 10.1165/rcmb.2009-0034OC, 19995943.
18. Osorio FG, Barcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo A, Freije JM, Lopez-Otin C. Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes Dev 2012, 26:2311-2324. 10.1101/gad.197954.112, 3475803, 23019125.
19. Gonzalez-Lopez A, Aguirre A, Lopez-Alonso I, Amado L, Astudillo A, Fernandez-Garcia MS, Suarez MF, Batalla-Solis E, Colado E, Albaiceta GM. MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia. PLoS One 2012, 7:e39940. 10.1371/journal.pone.0039940, 3386945, 22768176.
20. Garcia-Prieto E, Gonzalez-Lopez A, Cabrera S, Astudillo A, Gutierrez-Fernandez A, Fanjul-Fernandez M, Batalla-Solis E, Puente XS, Fueyo A, Lopez-Otin C, Albaiceta GM. Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 2010, 5:e13242. 10.1371/journal.pone.0013242, 2951918, 20949050.
21. dos Santos CC, Slutsky AS. The contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 2006, 68:585-618. 10.1146/annurev.physiol.68.072304.113443, 16460285.
22. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002, 110:1703-1716. 151632, 12464676.
23. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, Bryan AC. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987, 62:27-33.
24. Winn R, Maunder R, Chi E, Harlan J. Neutrophil depletion does not prevent lung edema after endotoxin infusion in goats. J Appl Physiol 1987, 62:116-121.
25. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989, 84:1609-1619. 10.1172/JCI114338, 304027, 2553777.
26. Bosnar M, Bosnjak B, Cuzic S, Hrvacic B, Marjanovic N, Glojnaric I, Culic O, Parnham MJ, Erakovic Haber V. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta. J Pharmacol Exp Ther 2009, 331:104-113. 10.1124/jpet.109.155838, 19633061.
27. Kawashima M, Yatsunami J, Fukuno Y, Nagata M, Tominaga M, Hayashi S. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung 2002, 180:73-89.
28. Ichiyama T, Nishikawa M, Yoshitomi T, Hasegawa S, Matsubara T, Hayashi T, Furukawa S. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother 2001, 45:44-47. 10.1128/AAC.45.1.44-47.2001, 90237, 11120942.
29. Yamaya M, Nishimura H, Hatachi Y, Yasuda H, Deng X, Sasaki T, Mizuta K, Kubo H, Nagatomi R. Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Antimicrob Agents Chemother 2012, 56:4052-4061. 10.1128/AAC.00259-12, 3421613, 22585227.
30. Kotani M, Kotani T, Li Z, Silbajoris R, Piantadosi CA, Huang YC. Reduced inspiratory flow attenuates IL-8 release and MAPK activation of lung overstretch. Eur Respir J 2004, 24:238-246. 10.1183/09031936.04.00128703, 15332391.
31. Sanz MJ, Nabah YN, Cerda-Nicolas M, O'Connor JE, Issekutz AC, Cortijo J, Morcillo EJ. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression. Br J Pharmacol 2005, 144:190-201. 1575992, 15665859.
32. Miyao N, Suzuki Y, Takeshita K, Kudo H, Ishii M, Hiraoka R, Nishio K, Tamatani T, Sakamoto S, Suematsu M. Various adhesion molecules impair microvascular leukocyte kinetics in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1059-L1068. 10.1152/ajplung.00365.2005, 16387754.
33. Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010, 36:612-620. 10.1007/s00134-009-1730-y, 19953222.
34. Friedlander AL, Albert RK. Chronic macrolide therapy in inflammatory airways diseases. Chest 2010, 138:1202-1212. 10.1378/chest.10-0196, 21051396.
35. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011, 44:725-738. 10.1165/rcmb.2009-0210ST, 21531958.
36. Gonzalez-Lopez A, Astudillo A, Garcia-Prieto E, Fernandez-Garcia MS, Lopez-Vazquez A, Batalla-Solis E, Taboada F, Fueyo A, Albaiceta GM. Inflammation and matrix remodeling during repair of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2011, 301:L500-L509. 10.1152/ajplung.00010.2011, 21743031.
37. Gonzalez-Lopez A, Albaiceta GM. Repair after acute lung injury: molecular mechanisms and therapeutic opportunities. Crit Care 2012, 16:209. 10.1186/cc11224, 22429641.
38. Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008, 34:619-630. 10.1007/s00134-007-0963-x, 18264692.
39. Curley GF, Contreras M, Higgins B, O'Kane C, McAuley DF, O'Toole D, Laffey JG. Evolution of the inflammatory and fibroproliferative responses during resolution and repair after ventilator-induced lung injury in the rat. Anesthesiology 2011, 115:1022-1032. 10.1097/ALN.0b013e31823422c9, 21952251.